Boulder, CONCT07124000Now EnrollingIRB Ready

Adenocarcinoma (NOS) Clinical Trial in Boulder, CO

Access cutting-edge adenocarcinoma (nos) treatment through this clinical trial at a research site in Boulder. Study-provided care at no cost to qualified participants.

Sponsored by AstraZeneca

Quick Self-Assessment

See if you qualify for this Boulder location

Preparing your pre-screening questions…

Expert Care in Boulder

Access adenocarcinoma (nos) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related adenocarcinoma (nos) treatment provided free

Apply for This Boulder Location

Check if you qualify for this adenocarcinoma (nos) clinical trial in Boulder, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boulder

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boulder site if eligible
  4. 4Begin participation

About This Adenocarcinoma (NOS) Study in Boulder

This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior systemic treatment for metastatic or advanced disease and have no satisfactory alternative treatment options in a real-world setting in the US

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

Adults aged ≥18 years
Patients with locally advanced, unresectable, or metastatic HER2-positive (IHC 3+) solid tumors who have received prior systemic treatment for metastatic or advanced disease and have no satisfactory alternative treatment options as determined by the Investigator (see

Exclusion Criteria

Criterion 1 for excluded solid tumors);
A clinician decision has been made for treatment with T-DXd in accordance with the FDA label;
HER2-positive (IHC 3+) by local testing prior to study enrolment at the time of signed and dated informed consent;
Patients who are willing and able to provide a signed and dated informed consent. Exclusion Criteria:
Primary diagnosis of adenocarcinoma of the breast, adenocarcinoma of the colon or rectum, NSCLC, adenocarcinoma of the gastric body or gastroesophageal junction or hematological malignancies;
Prior T-DXd therapy;
Patients without a baseline assessment of tumor burden undertaken prior to initiating T-DXd.
Patient is participating in a clinical trial at time of enrolment

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boulder?

Yes, this clinical trial (NCT07124000) has an active research site in Boulder, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Adenocarcinoma (NOS) Treatment Options in Boulder, CO

If you're searching for adenocarcinoma (nos) treatment options in Boulder, CO, this clinical trial (NCT07124000) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boulder research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adenocarcinoma (nos) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all adenocarcinoma (nos) clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Boulder, CO

See all alzheimers disease clinical trials recruiting in Boulder — not just this study.

Browse Alzheimers Disease Trials in Boulder →

Browse More Trials by Condition

Alzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Boulder?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boulder, CO